Edition:
India

Novan Inc (NOVN.OQ)

NOVN.OQ on NASDAQ Stock Exchange Global Market

5.36USD
2:29am IST
Change (% chg)

$-0.14 (-2.55%)
Prev Close
$5.50
Open
$5.54
Day's High
$5.54
Day's Low
$5.36
Volume
36,727
Avg. Vol
24,312
52-wk High
$30.39
52-wk Low
$3.52

Latest Key Developments (Source: Significant Developments)

Novan says ‍agreed to business structure to enable development of SB204 via 3rd party financing and execution
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Novan Inc ::Novan Inc -‍agreed to business structure to enable development of SB204 via 3rd party financing, 3rd party execution of additional Phase 3 pivotal trial​.Novan Inc - ‍proposed Phase 3 trial would be executed by third party's dermatology drug development team​.Novan Inc - a ‍new entity established by third party to provide capital to fund, expertise to execute additional Phase 3 pivotal trial for sb204​.  Full Article

Novan acquires IP rights to treat viral malignancies with nitric oxide
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Novan Inc :Novan acquires IP rights to treat viral malignancies with nitric oxide.Novan Inc- ‍ Has initiated clinical development of company's nitric oxide platform in field of immunology​.Novan Inc- ‍Top line results for phase 1b trial of co's nitric oxide platform​ are expected in Q2 of 2018.Novan Inc- ‍Targeting to begin phase 1b trial with SB414 in adults with atopic dermatitis before year end with top line results expected in Q3 of 2018​.  Full Article

BRIEF-Novan says ‍agreed to business structure to enable development of SB204 via 3rd party financing and execution

* Novan Inc -‍agreed to business structure to enable development of SB204 via 3rd party financing, 3rd party execution of additional Phase 3 pivotal trial​